ADC Therapeutics SA Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022
Revenue & cost
Revenue 118.31B0.00B232.700.03B0.00B
Cost of Revenue 0.00B0.00B0.00B
Gross Profit 0.03B-0.00B
Operating items
Amortization - Intangibles 252.0030.0047.00129.00118.00
Research & Development -0.00B-0.00B-0.00B-0.00B
Selling, General & Administrative -0.00B-0.00B-0.00B-0.00B
Restructuring Costs 0.01B
Other Operating Expenses -0.00B-0.01B-0.00B
Operating Expenses -0.00B-0.00B-0.00B-0.00B
Operating Income -0.12B-0.22B-0.26B-0.12B
EBIT -0.12B-0.22B-0.26B-0.12B
Non-operating items
Interest & Investment Income -0.00B0.00B-832.00-66.000.00B
Other Non Operating Income 0.00B-0.00B-0.00B
Non Operating Income 0.00B-0.00B0.00B-0.00B
Net income details
EBT -0.00B-0.00B-0.00B-0.00B
Tax Provisions -582.00-327.000.00B-0.00B
Profit After Tax -0.00B-0.00B-0.00B-0.00B
Income from Continuing Operations -0.00B-0.00B-0.00B-0.00B
Consolidated Net Income -0.00B-0.00B-0.00B-0.00B
Income towards Parent Company -0.00B-0.00B-0.00B-0.00B
Net Income towards Common Stockholders -0.00B-0.00B-0.00B-0.00B
Additional items
EPS (Basic) 0.000.000.000.00
Shares Outstanding (Weighted Average) 0.07B0.07B0.08B0.08B
EBITDA -0.12B-0.22B-0.26B-0.12B
Interest Expenses -3.00-2.70-2.60
Tax Rate 0.50%0.13%0.74%